The name Clay Siegall may not stand out when being spoken. The name itself is fairly common, but there’s nothin common about the Clay Siegall who’s involved in cancer research. This guy is accomplished in more ways than one, and he has revolutionized the industry thanks to his valiant effort. Clay Siegall is a man of many talents as he is known to be an author, a motivational speaker, a scientist, a mentor and a doctor. The guy just so happens to be the president for one of the world’s top cancer research institutions. On top of that, Siegall has a Ph.D in Genetics from George Washington University, and he has a B.S. in Zoology from the University of Maryland.
Siegall’s valiant quest to fight this deadly disease started out when he was in college. His father struggled with the disease for many years, and it was devastating on his body. At that time, cancer fighting medications were very aggressive, which caused pain, sickness and amputation. Siegall set out on finding more progressive ways for dealing with the disease, which eventually led to the inception of Seattle Genetics. In 1998, Seattle Genetics made its debut, but times were tough in the beginning. The small Seattle-based company wasn’t making much of a profit. Siegall had to readdress the issue as well as readdress the situation. After brainstorming for ideas, Siegall brought in a talented team of salesmen. This implementation would eventually lead to success because this team was securing 7-fugure deals on a consistent basis.
As of today, Seattle Genetics earn its revenue through multiple channels. This includes licensing its own technologies, providing production partnerships and selling its proprietary medications. Seattle Genetics’ ADCETRIS drug has brought in $350 million by itself, and it is one of the most successful cancer fighting medications on the market today. Clay Siegall has done an extraordinary job over the years and it doesn’t look like he’s slowing down anytime soon.